Ivan Horak

Dr. Ivan Horak has extensive experience in the global pharmaceutical industry. He was former Chief Scientific and Medical Officer at Tessa Therapeutics. Prior to that, he was Head of Global R&D and Chief Scientific and Medical Officer at Symphogen. He also served as President of R&D at Enzon Pharmaceuticals. Dr. Horak has held leadership positions in various pharmaceutical companies as well as at the National Cancer Institute (NCI). During his career, Dr. Horak has successfully led a number of FDA new drug applications. Dr. Horak is a member of the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and European Society of Medical Oncology (ESMO). He also published over 90 scientific articles and book chapters. Dr. Ivan Horak is a board-certified medical oncologist.